The evidence suggests that beyond GBM, colorectal cancer, small cell lung cancer, IDH mutant astrocytoma, and oligodendroglioma could benefit from a deeper understanding of MGMT methylation dynamics. The gene discussed is MGMT; the disease is small cell lung carcinoma.